glp 1 drugs and anesthesia The Impact of GLP-1 Receptor Agonists on Sedation Anesthetic Considerations for Patients Taking

2014Glucagonoma-induced acute heart failure

Lets dive in

2) [13, 14], dispelling the common notion that injectable therapies are a last resort or restricted only to those individuals who fail to respond to maximal doses of oral agents

& Bluher, M

Cardiovascular effects Heart rate increased in a dose-dependent manner during the first 24 weeks of treatment, with the largest average increase being approximately 6.7 beats per minute at the 12 mg dose

This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License ( which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made